Category: Small Intestine

P2537 - CD117+ Exosomes and Mast Cells From Hereditary Alpha Tryptasemia Patients Reveal Unique Phosphorylation, Lipidomics, and Proteomics Profiles

Tuesday, October 9
10:30 AM – 4:00 PM



Award: Category Award (Small Intestine)

Award: Presidential Poster Award

Category: Small Intestine       

Abdel A. Alli, PhD1, Liza Konnikova, MD, PhD2, Kubra Tuna, MD1, Nancy Denslow, PhD1, Mohammad-Zaman Nouri, PhD1, Jin Koh, MD, PhD1, Jian Li, MD, PhD1, Ying Tang, BS1, J. Forrest Shirley, MS1, Lisa K. Ryan, PhD3, Jonathan J. Lyons, MD4, Joshua D. Milner, MD4, Scott B. Snapper, MD, PhD5, Sarah C. Glover, DO6

1University of Florida College of Medicine, Gainesville, FL; 2University of Pittsburgh/UPMC Children's Hospital, Pittsburgh, PA; 3Department of Medicine, Gainesville, FL; 4NIAID/NIH, Bethesda, MD; 5Harvard Medical School/Boston Children's Hospital, Boston, MA; 6University of Florida, Gainesville, FL

Introduction: Hereditary alpha tryptasemia (HαT) is a recently described autosomal dominant condition caused by increased TPSAB1 copy number, resulting in over-expression of alpha-tryptase (Lyons et al. Nat. Genet. 2016 Dec;48(12): 1564-1569.). It is reported to affect 3-5% of the general population and is associated with a variety of gastrointestinal (GI) complaints including GI dismotility, inflammation, abdominal pain and GERD.

Methods: The mast cell (MC) of these patients were further characterized by examining the lamina propria mononuclear cells (LPMC) isolated from ileal biopsies of HαT, Crohn’s disease (CD) and systemic mastocytosis (SM) patients by CyTOF. To elevate this characterization further, we examined expression patterns of these markers in the duodenum of HαT patients compared with IBS patients by immunohistochemistry (IHC). Since exosomes reflect the composition of cell membranes in tissue, we also evaluated urinary exosomes in these patients.

Results: Our 22-patient cohort with a confirmed HαT diagnosis had a mean basal serum tryptase of 15.4 and a mean MC number per high powered field (hpf) of 50.6 in small bowel histopathology sections. Non-HαT patients have < 8.5 μg/L tryptase and < 20/hpf MC (the MC/hpf number is debated: Gastroenterol. Hepatol. (NY) 2010 Dec; 6(12): 772-777). Defining MC by CD117+ and FcεR1+, we found that MCs were increased in HαT patients compared with patients with quiescent CD. Furthermore, MC from HαT patients expressed HLA-DR (MHC Class II antigen). Additionally, CyTOF data revealed T-helper (Th) lymphocytes (CD4+ T-cells) with CXCR5 in HαT LPMC compared with CD4+ T-cells form CD and SM. In HαT patient sections, there were elevated numbers of CD117+FcεR1+ cells with HLA-DR compared with the IBS patient sections where a paucity of cells with these characteristics were observed. We noted that the exosome lipidomics were consistent with a MC signature. Flow cytometry revealed that a portion of the HαT exosomes had an MC marker, CD117+. Proteomics data revealed that multiple pathways, including mTOR and protease-activated receptor 1 (PAR1), were elevated. CyTOF data on LPMC confirmed an increase in phosphorylated S6, which is downstream from mTOR, in HαT patients compared with CD patients.

Discussion: Taken together, the data suggest that MC could be potentially acting as antigen presenting cells (APC) in HαT patients.

Disclosures: Does Disclose

Abdel Alli indicated no relevant financial relationships.
Liza Konnikova indicated no relevant financial relationships.
Kubra Tuna indicated no relevant financial relationships.
Nancy Denslow indicated no relevant financial relationships.
Mohammad-Zaman Nouri indicated no relevant financial relationships.
Jin Koh indicated no relevant financial relationships.
Jian Li indicated no relevant financial relationships.
Ying Tang indicated no relevant financial relationships.
J. Forrest Shirley indicated no relevant financial relationships.
Lisa Ryan indicated no relevant financial relationships.
Jonathan Lyons indicated no relevant financial relationships.
Joshua Milner indicated no relevant financial relationships.
Scott Snapper: Celgene – Grant/Research Support. Janssen – Grant/Research Support. Pfizer – Grant/Research Support. Takada – Grant/Research Support.
Sarah Glover: ABBVIE – Grant/Research Support. Celgene – Grant/Research Support. Genentech – Grant/Research Support. Gilead – Grant/Research Support. Janssen – Grant/Research Support. Shire – Grant/Research Support. Takada – Advisory Committee/Board Member, Grant/Research Support.



Citation: Abdel A. Alli, PhD; Liza Konnikova, MD, PhD; Kubra Tuna, MD; Nancy Denslow, PhD; Mohammad-Zaman Nouri, PhD; Jin Koh, MD, PhD; Jian Li, MD, PhD; Ying Tang, BS; J. Forrest Shirley, MS; Lisa K. Ryan, PhD; Jonathan J. Lyons, MD; Joshua D. Milner, MD; Scott B. Snapper, MD, PhD; Sarah C. Glover, DO. CD117+ EXOSOMES AND MAST CELLS FROM HEREDITARY ALPHA TRYPTASEMIA PATIENTS REVEAL UNIQUE PHOSPHORYLATION, LIPIDOMICS, AND PROTEOMICS PROFILES. Program No. P2537. ACG 2018 Annual Scientific Meeting Abstracts. Philadelphia, Pennsylvania: American College of Gastroenterology.

Sarah Glover